Expression of SGLT1 and SGLT2 in Breast Cancer and Potential Anticancer Effects of SGLT1 Inhibitors

被引：0
|
作者：
Tsunokake, Satoko [1 ]
Iwabichi, Erina [2 ]
Miki, Yasuhiro [3 ]
Kanai, Ayako [4 ]
Onodera, Yoshiaki [3 ]
Ishida, Takanori [1 ]
Sasano, Hironobu [3 ]
Suzuki, Takashi [2 ,3 ,5 ]
机构：
[1] Tohoku Univ, Dept Breast & Endocrine Surg Oncol, Sendai, Miyagi, Japan
[2] Tohoku Univ, Dept Pathol & Histotechnol, Sendai, Miyagi, Japan
[3] Tohoku Univ, Dept Anat Pathol, Sendai, Miyagi, Japan
[4] Hachinohe Municipal Hosp, Dept Breast Surg, Hachinohe, Aomori, Japan
[5] Tohoku Univ Hosp, Dept Pathol, Sendai, Miyagi, Japan
来源：
CANCER SCIENCE | 2024年 / 115卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P-3266
引用
收藏
页码：1939 / 1939
页数：1
相关论文
共 50 条
  • [21] SGLT1/2 expression in the heart of transplanted patients is associated with inflammatory induction of oxidative stress: potential protective effect of SGLT2 inhibitors
    Gong, D. S.
    Mroueh, A.
    Matsushita, K.
    Fakih, W.
    Auger, C.
    Oak, M. H.
    Pieper, M. P.
    Morel, O.
    Epailly, E.
    Schini-Kerth, V.
    EUROPEAN HEART JOURNAL, 2022, 43 : 3007 - 3007
  • [22] Dual SGLT1 and SGLT2 inhibition: more than the sum of its parts
    Sanchez-Munoz, Enrique
    Requena-Ibanez, Juan Antonio
    Badimon, Juan Jose
    REVISTA ESPANOLA DE CARDIOLOGIA, 2024, 77 (07): : 510 - 514
  • [23] Localizations of Na+-d-glucose cotransporters SGLT1 and SGLT2 in human kidney and of SGLT1 in human small intestine, liver, lung, and heart
    Ivana Vrhovac
    Daniela Balen Eror
    Dirk Klessen
    Christa Burger
    Davorka Breljak
    Ognjen Kraus
    Nikola Radović
    Stipe Jadrijević
    Ivan Aleksic
    Thorsten Walles
    Christoph Sauvant
    Ivan Sabolić
    Hermann Koepsell
    Pflügers Archiv - European Journal of Physiology, 2015, 467 : 1881 - 1898
  • [24] Molecular docking and dynamics simulation of Orthosiphon stamineus against SGLT1 and SGLT2
    Subbiah, Usha
    Ajith, Athira
    Subbiah, Harini Venkata
    JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2023, 41 (23): : 13663 - 13678
  • [25] The Na+-D-glucose cotransporters SGLT1 and SGLT2 are targets for the treatment of diabetes and cancer
    Koepsell, Hermann
    PHARMACOLOGY & THERAPEUTICS, 2017, 170 : 148 - 165
  • [26] Localizations of Na+-D-glucose cotransporters SGLT1 and SGLT2 in human kidney and of SGLT1 in human small intestine, liver, lung, and heart
    Vrhovac, Ivana
    Eror, Daniela Balen
    Klessen, Dirk
    Burger, Christa
    Breljak, Davorka
    Kraus, Ognjen
    Radovic, Nikola
    Jadrijevic, Stipe
    Aleksic, Ivan
    Walles, Thorsten
    Sauvant, Christoph
    Sabolic, Ivan
    Koepsell, Hermann
    PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY, 2015, 467 (09): : 1881 - 1898
  • [27] Physiology of renal glucose handling via SGLT1, SGLT2 and GLUT2
    Chiara Ghezzi
    Donald D. F. Loo
    Ernest M. Wright
    Diabetologia, 2018, 61 : 2087 - 2097
  • [28] Does SGLT1 Inhibition Add Benefit to SGLT2 Inhibition in Type 2 Diabetes?
    Pitt, Bertram
    Bhatt, Deepak L.
    CIRCULATION, 2021, 144 (01) : 4 - 6
  • [29] Physiology of renal glucose handling via SGLT1, SGLT2 and GLUT2
    Ghezzi, Chiara
    Loo, Donald D. F.
    Wright, Ernest M.
    DIABETOLOGIA, 2018, 61 (10) : 2087 - 2097
  • [30] SGLT1 does compensate for SGLT2 inhibition (vol 2, pg 256, 2016)
    de Leeuw
    EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY, 2018, 4 (02) : 101 - 101
12345